Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inflammatory Breast Cancer Stage III”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT00346229
What this trial is testing

Temperature-Sensitive Liposomal Doxorubicin and Hyperthermia in Treating Women With Locally Recurrent Breast Cancer

Who this might be right for
Breast Cancer
Duke University 29
Testing effectiveness (Phase 2)UnknownNCT00398489
What this trial is testing

Docetaxel, Epirubicin, and Cyclophosphamide With or Without Trastuzumab in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery

Who this might be right for
Breast Cancer
Technical University of Munich 94
Testing effectiveness (Phase 2)Study completedNCT00464646
What this trial is testing

Therapy With Bevacizumab (BEV), Epirubicin, and Cyclophosphamide Followed by Docetaxel Plus Trastuzumab and BEV Given as Neoadjuvant or Adjuvant Therapy for Women With Locally Advanced HER2 Positive Invasive Breast Cancer

Who this might be right for
Breast Cancer
NSABP Foundation Inc 105
Not applicableUnknownNCT00005058
What this trial is testing

Enhanced Ultrasound in Determining Extent of Disease in Women With Primary Breast Cancer

Who this might be right for
Breast Cancer
Royal Marsden NHS Foundation Trust
Testing effectiveness (Phase 2)Looking for participantsNCT05795101
What this trial is testing

TRUDI: TDXD+Durva in HER2+/Low IBC

Who this might be right for
Invasive Breast CancerInflammatory Breast Cancer Stage IIIHER2-positive Breast Cancer+2 more
Filipa Lynce, MD 63
Testing effectiveness (Phase 2)Study completedNCT00070252
What this trial is testing

Neoadjuvant Tipifarnib, Docetaxel, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIA or Stage IIIB Breast Cancer

Who this might be right for
Adult Solid NeoplasmInflammatory Breast CarcinomaMale Breast Carcinoma+2 more
National Cancer Institute (NCI) 53
Testing effectiveness (Phase 2)WithdrawnNCT05177796
What this trial is testing

Panitumumab and Pembrolizumab in Combination With Neoadjuvant Chemotherapy for the Treatment of Stage III-IV Triple Negative Breast Cancer

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+10 more
M.D. Anderson Cancer Center
Not applicableStudy completedNCT01048918
What this trial is testing

Characterization of Circulating Tumor Cells (CTC-s) in Patients With Locally Advanced or Metastatic Stage IV Breast Cancer

Who this might be right for
Locally Advanced Breast CancerMetastatic (Stage IV) Breast CancerStage III-IV Breast Cancer or Inflammatory
City of Hope Medical Center 280
Large-scale testing (Phase 3)UnknownNCT00003680
What this trial is testing

Standard Chemotherapy Compared With High-Dose Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Women With Advanced or Inflammatory Breast Cancer

Who this might be right for
Breast Cancer
Scottish Cancer Therapy Network 300
Testing effectiveness (Phase 2)Study completedNCT00003199
What this trial is testing

Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer

Who this might be right for
Estrogen Receptor-negative Breast CancerEstrogen Receptor-positive Breast CancerInflammatory Breast Cancer+5 more
Fred Hutchinson Cancer Center 50
Large-scale testing (Phase 3)UnknownNCT02879513
What this trial is testing

Trial of Adjuvant Chemotherapy in Breast Cancer Patients With Pathological Partial Response and Complete Response to Neoadjuvant Chemotherapy

Who this might be right for
Invasive Ductal Breast CancerTubular Breast CancerMucinous Breast Cancer+1 more
RenJi Hospital 290
Testing effectiveness (Phase 2)Study completedNCT00820547
What this trial is testing

Efficacy and Tolerance Study of Bevacizumab in Her2- Inflammatory Breast Cancer Patients

Who this might be right for
Breast Cancer
UNICANCER 100
Testing effectiveness (Phase 2)Study completedNCT00004925
What this trial is testing

Liposomal Doxorubicin and Trastuzumab in Treating Women With Locally Advanced, Inflammatory, or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center
Large-scale testing (Phase 3)Ended earlyNCT00016276
What this trial is testing

Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer

Who this might be right for
Cardiac ToxicityInflammatory Breast CancerStage IIIA Breast Cancer+2 more
National Cancer Institute (NCI) 396
Testing effectiveness (Phase 2)Active Not RecruitingNCT03012100
What this trial is testing

Multi-epitope Folate Receptor Alpha Peptide Vaccine, GM-CSF, and Cyclophosphamide in Treating Patients With Triple Negative Breast Cancer

Who this might be right for
Bilateral Breast CarcinomaBreast Inflammatory CarcinomaStage IB Breast Cancer AJCC v7+9 more
Academic and Community Cancer Research United 280
Testing effectiveness (Phase 2)Study completedNCT01417286
What this trial is testing

Accelerated Radiation Therapy After Surgery in Treating Patients With Breast Cancer

Who this might be right for
Inflammatory Breast CancerInvasive Ductal Breast CarcinomaInvasive Lobular Breast Carcinoma+7 more
Rutgers, The State University of New Jersey 69
Post-approval studies (Phase 4)WithdrawnNCT02637466
What this trial is testing

Vortioxetine for MDD, Cognition, and Systemic Inflammatory Biomarkers

Who this might be right for
Unipolar Major DepressionStage I, II or III Breast Cancer
University of Miami
Testing effectiveness (Phase 2)Study completedNCT00049114
What this trial is testing

Tipifarnib, Doxorubicin, and Cyclophosphamide in Treating Women With Locally Advanced Breast Cancer

Who this might be right for
Inflammatory Breast CancerStage II Breast CancerStage IIIA Breast Cancer+2 more
National Cancer Institute (NCI) 62
Testing effectiveness (Phase 2)Active Not RecruitingNCT02971748
What this trial is testing

Pembrolizumab in Treating Patients With Hormone Receptor Positive, Localized Inflammatory Breast Cancer Who Are Receiving Hormone Therapy and Did Not Achieve a Pathological Complete Response to Chemotherapy

Who this might be right for
Anatomic Stage IIIB Breast Cancer AJCC v8Anatomic Stage IIIC Breast Cancer AJCC v8Breast Inflammatory Carcinoma+2 more
M.D. Anderson Cancer Center 36
Testing effectiveness (Phase 2)Study completedNCT00066443
What this trial is testing

Epirubicin, Docetaxel, and Pegfilgrastim in Treating Women With Locally Advanced or Inflammatory Breast Cancer

Who this might be right for
Breast Cancer
NCIC Clinical Trials Group 93
Next Page